Przemysław Holko

10PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMedicine, nursing and health curriculum and pedagogyRadiation therapyFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 23, 2026
Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

|Dec 31, 2025
Determinants of the Availability of Special Diet Meals in Public Schools from Kraków (Poland): A Cross-Sectional Analysis.

Beata Piórecka, Ewa Błaszczyk-Bębenek, Przemysław Holko

|Sep 13, 2025
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

Holger N Lode, Przemysław Holko, Aleksandra Wieczorek

|Nov 09, 2024
Predictors of Dietary Supplement Use Among Children Attending Care and Educational Institutions in Krakow, Poland.

Beata Piórecka, Przemysław Holko, Weronika Olesiak

|Sep 25, 2024
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysis.

Paweł Moćko, Magdalena Koperny, Katarzyna Śladowska

|Oct 19, 2022
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries.

Przemysław Holko, Paweł Kawalec, Magdalena Sajak-Szczerba

Pageof 2

Frequent Collaborators

3 joint publications

Paweł Kawalec

2 joint publications

Katarzyna Śladowska

2 joint publications

Iwona Kowalska-Bobko

2 joint publications

Beata Piórecka